Metaplastic breast carcinomas are basal-like tumours (Q33250228)

24 July 2017

Metaplastic breast carcinomas are basal-like tumours (English)

1 reference

24 July 2017

8

Lakhani SR

1 reference

24 July 2017

6

Nesland JM

1 reference

24 July 2017

Reis-Filho JS

1

1 reference

24 July 2017

Milanezi F

2

1 reference

24 July 2017

Steele D

3

1 reference

24 July 2017

Savage K

4

1 reference

24 July 2017

Simpson PT

5

1 reference

24 July 2017

Pereira EM

7

1 reference

24 July 2017

Schmitt FC

9

1 reference

24 July 2017

1 July 2006

1 reference

24 July 2017

1 reference

24 July 2017

49

1 reference

24 July 2017

1

1 reference

24 July 2017

10-21

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

24 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic carcinomas of the breast. II. Spindle cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Maspin expression in myoepithelial tumors of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

p63 expression in sarcomatoid/metaplastic carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02467.X

10.1111/J.1365-2559.2006.02467.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference